HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN for Prophylaxis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 33 adverse event reports in the FDA FAERS database where HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN was used for Prophylaxis.
Most Reported Side Effects for HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 43 | 34.7% | 0 | 2 |
| Hepatitis b | 34 | 27.4% | 3 | 0 |
| Disease recurrence | 9 | 7.3% | 2 | 0 |
| Concomitant disease aggravated | 7 | 5.7% | 0 | 0 |
| Vaccination complication | 7 | 5.7% | 0 | 0 |
| Viral mutation identified | 7 | 5.7% | 0 | 0 |
| Anaphylactic reaction | 6 | 4.8% | 0 | 2 |
| Expired product administered | 5 | 4.0% | 0 | 0 |
| Foetal exposure during pregnancy | 5 | 4.0% | 1 | 0 |
Other Indications for HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Product used for unknown indication (23)
Antiviral prophylaxis (22)
Hepatitis b (13)
Liver transplant (5)
Other Drugs Used for Prophylaxis
PEGFILGRASTIM (7,424)
HUMAN C1-ESTERASE INHIBITOR (5,950)
DENOSUMAB (4,541)
SULFAMETHOXAZOLE\TRIMETHOPRIM (3,197)
ASPIRIN (2,083)
VALACYCLOVIR (1,574)
PANTOPRAZOLE (1,502)
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN (1,444)
CLOPIDOGREL BISULFATE (1,296)
ENOXAPARIN (1,278)